Browse By Topic Clinical Microbiology
ASM hails the inclusion of $1.75 billion for CDC’s Advanced Molecular Detection (AMD) program in the American Rescue Plan Act signed into law by President Biden.
ASM responds to the House Energy & Commerce Subcommittee on Health Hearing: “Road to Recovery: Ramping Up COVID-19 Vaccines, Testing and Medical Supply Chain."
The high demand for COVID-19 testing has impacted lab supply chains since the pandemic's early days. Now, unprecedented supply shortages for non-COVID-19 tests are affecting diagnostic testing for many other diseases.